Tryptophan


Generic Medicine Info
Contraindications
History of eosinophilia-myalgia syndrome associated with tryptophan treatment.
Special Precautions
May affect ability to drive or operate machinery. Monitor for suicidal thoughts or clinical worsening of depression during initial treatment period. Renal or hepatic impairment. Elderly.
Adverse Reactions
Nausea (take after food to minimise nausea), headache, lightheadedness, drowsiness, eosinophilia-myalgia syndrome.
Drug Interactions
Increased risk of serotonin syndrome with SSRI. Possible decrease in levodopa plasma levels with tryptophan.
CIMS Class
Antidepressants
ATC Classification
N06AX02 - tryptophan ; Belongs to the class of other antidepressants.
Disclaimer: This information is independently developed by CIMS based on tryptophan from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in